The Lung Cancer Research Foundation (LCRF) is excited to announce a partnership with leading lung cancer…
Author: admin
Choice Health at Home Announces Multiple Acquisitions in Texas and Oklahoma
Choice Health at Home, LLC (“Choice”) announced today the acquisition of multiple home health and hospice…
Cantel Medical LLC Announces Offer to Purchase Relating to Outstanding Convertible Senior Notes
Cantel Medical LLC, formerly known as Cantel Medical Corp. (the “Company,” “Cantel,” “we” or “our”), today…
FieldLine Launches HEDscan™, a Next-Generation Device for Non-Invasive Functional Brain Imaging
FieldLine Inc., a biotech company targeting advanced brain diagnostic technology, announced today the general availability of…
Bridge Biotherapeutics Announces the Initiation of the Proof of Mechanism Study for BBT-401 in Patients with Ulcerative Colitis
Bridge Biotherapeutics (KQ288330) today announced the first patient dosing of BBT-401 in its open label, proof…
Novartis Cosentyx receives FDA approval for treatment of children and adolescents with moderate to severe plaque psoriasis
Novartis, a leader in immuno-dermatology and rheumatology, today announced the U.S. Food and Drug Administration (FDA)…
Predictive Health Diagnostics Company’s Proprietary Computational Technology Enables Development of Specialty Diagnostic Tests to Improve Patient Care
Predictive Health Diagnostics Company, Inc. (“PHDC” or “the Company”), a diagnostics development platform company that develops, manufactures, and…
Stealth BioTherapeutics Receives Orphan Drug Designation from the European Medicines Agency for Elamipretide for the Treatment of Barth Syndrome
Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development, and commercialization of…
Vicarious Surgical CEO Adam Sachs to Present at Surgical Disruptive Technology Summit
Vicarious Surgical Inc. (“Vicarious” or “Vicarious Surgical” or the “Company”), a next-generation robotics technology company seeking…
Viracta Therapeutics to Present at the Jefferies Virtual Healthcare Conference
Viracta Therapeutics, Inc. (Viracta or the Company), a precision oncology company targeting virus-associated malignancies, today announced that…